157 related articles for article (PubMed ID: 36583484)
1. MiR-101-3p targets KPNA2 to inhibit the progression of lung squamous cell carcinoma cell lines.
Dong L; Jiang H; Qiu T; Xu Y; Chen E; Huang A; Ying K
Histol Histopathol; 2023 Oct; 38(10):1169-1178. PubMed ID: 36583484
[TBL] [Abstract][Full Text] [Related]
2. MiR-101-3p Suppresses Progression of Cervical Squamous Cell Carcinoma by Targeting and Down-Regulating KPNA2.
Wang H; Xiao R; Yang B
Technol Cancer Res Treat; 2021; 20():15330338211055948. PubMed ID: 34816790
[No Abstract] [Full Text] [Related]
3. MiR-139-3p Targets CHEK1 Modulating DNA Repair and Cell Viability in Lung Squamous Carcinoma Cells.
Zheng X; Zhang Y; Wu S; Jiang B; Liu Y
Mol Biotechnol; 2022 Jul; 64(7):832-840. PubMed ID: 35150405
[TBL] [Abstract][Full Text] [Related]
4. MiR-101-3p Regulates the Viability of Lung Squamous Carcinoma Cells via Targeting EZH2.
Hou Y; Li L; Ju Y; Lu Y; Chang L; Xiang X
J Cell Biochem; 2017 Oct; 118(10):3142-3149. PubMed ID: 27966775
[TBL] [Abstract][Full Text] [Related]
5. MiR-210-3p targets CELF2 to facilitate progression of lung squamous carcinoma through PI3K/AKT pathway.
Zhang Q; Wang Y
Med Oncol; 2022 Aug; 39(11):161. PubMed ID: 35972577
[TBL] [Abstract][Full Text] [Related]
6. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
Li H; Zhao Q; Tang Z
Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
[TBL] [Abstract][Full Text] [Related]
7. miR-223-5p Suppresses OTX1 to Mediate Malignant Progression of Lung Squamous Cell Carcinoma Cells.
Lu Y
Comput Math Methods Med; 2021; 2021():6248793. PubMed ID: 34306176
[TBL] [Abstract][Full Text] [Related]
8. MIR205HG acts as a ceRNA to expedite cell proliferation and progression in lung squamous cell carcinoma via targeting miR-299-3p/MAP3K2 axis.
Liu L; Li Y; Zhang R; Li C; Xiong J; Wei Y
BMC Pulm Med; 2020 Jun; 20(1):163. PubMed ID: 32513149
[TBL] [Abstract][Full Text] [Related]
9. LncRNA GAS5 modulates the progression of non-small cell lung cancer through repressing miR-221-3p and up-regulating IRF2.
Ma J; Miao H; Zhang H; Ren J; Qu S; Da J; Xu F; Zhao H
Diagn Pathol; 2021 May; 16(1):46. PubMed ID: 34022918
[TBL] [Abstract][Full Text] [Related]
10. CREB1 regulates KPNA2 by inhibiting mir-495-3p transcription to control melanoma progression : The role of the CREB1/miR-495-3p/KPNA2 axis in melanoma progression.
Geng X; Qiu X; Gao J; Gong Z; Zhou X; Liu C; Luo H
BMC Mol Cell Biol; 2022 Dec; 23(1):57. PubMed ID: 36522613
[TBL] [Abstract][Full Text] [Related]
11. Downregulation of N-Acetylglucosaminyltransferase GCNT3 by miR-302b-3p Decreases Non-Small Cell Lung Cancer (NSCLC) Cell Proliferation, Migration and Invasion.
Li Q; Ran P; Zhang X; Guo X; Yuan Y; Dong T; Zhu B; Zheng S; Xiao C
Cell Physiol Biochem; 2018; 50(3):987-1004. PubMed ID: 30355927
[TBL] [Abstract][Full Text] [Related]
12. Circular RNA circ_0079593 promotes glioma development through regulating KPNA2 expression by sponging miR-499a-5p.
Yang Z; Li C; Fan XY; Liu LJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(3):1288-1301. PubMed ID: 32096160
[TBL] [Abstract][Full Text] [Related]
13. LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.
Peng BH; Ji YF; Qiu XJ
J Clin Lab Anal; 2022 Jul; 36(7):e24506. PubMed ID: 35588441
[TBL] [Abstract][Full Text] [Related]
14. MiR-552-3p facilitated cell proliferation, migration and invasion by sponging Fibulin 5 in non-small cell lung cancer via activation of ERK/GSK3β/β-catenin signaling pathway.
Huang M; Liao X; Li L; Li G; Chen M
Tissue Cell; 2021 Dec; 73():101672. PubMed ID: 34736163
[TBL] [Abstract][Full Text] [Related]
15. MiR-4652-5p Targets RND1 to Regulate Cell Adhesion and Promote Lung Squamous Cell Carcinoma Progression.
Zhou Y; Yan J; Chen H; Zhou W; Xiao G; Zou H; Yang J
Appl Biochem Biotechnol; 2022 Jul; 194(7):3031-3043. PubMed ID: 35334070
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA TUG1 decreases bladder cancer chemo-sensitivity toward doxorubicin through elevating KPNA2 expression and activating the PI3K/AKT pathway via adsorbing miR-582-5p.
Lu P; Jiang Y; Xia Z
Anticancer Drugs; 2023 Jan; 34(1):144-154. PubMed ID: 36539367
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated
Sui J; Zhao Q; Zhang Y; Liang G
DNA Cell Biol; 2022 Mar; 41(3):319-329. PubMed ID: 35244469
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway.
Wei CH; Wu G; Cai Q; Gao XC; Tong F; Zhou R; Zhang RG; Dong JH; Hu Y; Dong XR
J Hematol Oncol; 2017 Jun; 10(1):125. PubMed ID: 28629431
[TBL] [Abstract][Full Text] [Related]
19. LncRNA SNHG1 influences cell proliferation, migration, invasion, and apoptosis of non-small cell lung cancer cells via the miR-361-3p/FRAT1 axis.
Li X; Zheng H
Thorac Cancer; 2020 Feb; 11(2):295-304. PubMed ID: 31788970
[TBL] [Abstract][Full Text] [Related]
20. MiR-497-5p down-regulates CDCA4 to restrains lung squamous cell carcinoma progression.
Hu J; Xiang X; Guan W; Lou W; He J; Chen J; Fu Y; Lou G
J Cardiothorac Surg; 2021 Nov; 16(1):330. PubMed ID: 34772428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]